Latest Insider Transactions at Orthopediatrics Corp (KIDS)
This section provides a real-time view of insider transactions for Orthopediatrics Corp (KIDS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ORTHOPEDIATRICS CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ORTHOPEDIATRICS CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 21
2024
|
Daniel J Gerritzen General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
10,000
-11.45%
|
$290,000
$29.3 P/Share
|
|
Jun 11
2024
|
David R Bailey President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
90,395
+28.23%
|
-
|
|
Jun 11
2024
|
Fred Hite COO and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
57,018
+27.4%
|
-
|
|
Jun 11
2024
|
Gregory A Odle President of Scoliosis |
BUY
Grant, award, or other acquisition
|
Direct |
34,901
+23.22%
|
-
|
|
Jun 11
2024
|
Mark C Throdahl Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,623
+11.94%
|
-
|
|
Jun 11
2024
|
Joseph W Hauser Pres. Trauma & Def. Correction |
BUY
Grant, award, or other acquisition
|
Direct |
37,936
+29.47%
|
-
|
|
Jun 11
2024
|
Daniel J Gerritzen General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
34,901
+28.56%
|
-
|
|
Jun 10
2024
|
Harold Ruf Director |
BUY
Bona fide gift
|
Indirect |
2,766
+12.57%
|
-
|
|
Jun 10
2024
|
Harold Ruf Director |
SELL
Bona fide gift
|
Direct |
2,766
-100.0%
|
-
|
|
May 28
2024
|
David R Pelizzon Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,766
+10.13%
|
-
|
|
May 28
2024
|
Bryan W Hughes Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,766
+17.74%
|
-
|
|
May 28
2024
|
Terry D Schlotterback Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,766
+13.18%
|
-
|
|
May 28
2024
|
George Sinclair Mitchell Dyer Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,766
+36.89%
|
-
|
|
May 28
2024
|
Samuel D Riccitelli Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,766
+18.7%
|
-
|
|
May 28
2024
|
(Reynolds) Marie C Infante Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,766
+19.57%
|
-
|
|
May 28
2024
|
Harold Ruf Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,766
+30.42%
|
-
|
|
May 28
2024
|
Jimmy Duane Mc Donald Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,766
+36.89%
|
-
|
|
Mar 11
2024
|
Fred Hite COO and CFO |
SELL
Open market or private sale
|
Direct |
3,195
-3.28%
|
$86,265
$27.59 P/Share
|
|
Mar 11
2024
|
Mark C Throdahl Director |
SELL
Open market or private sale
|
Direct |
2,433
-1.73%
|
$65,691
$27.59 P/Share
|
|
Mar 11
2024
|
Gregory A Odle President of Scoliosis |
SELL
Open market or private sale
|
Direct |
2,768
-3.33%
|
$74,736
$27.59 P/Share
|
|
Mar 11
2024
|
Daniel J Gerritzen General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
2,741
-4.97%
|
$74,007
$27.59 P/Share
|
|
Mar 11
2024
|
David R Bailey President and CEO |
SELL
Open market or private sale
|
Direct |
3,213
-2.25%
|
$86,751
$27.59 P/Share
|
|
Feb 22
2024
|
Joseph W Hauser Pres. Trauma & Def. Correction |
SELL
Open market or private sale
|
Direct |
2,903
-5.21%
|
$81,284
$28.06 P/Share
|
|
Dec 21
2023
|
David R Bailey President and CEO |
SELL
Bona fide gift
|
Direct |
1,200
-0.83%
|
-
|
|
Aug 11
2023
|
Terry D Schlotterback Director |
SELL
Open market or private sale
|
Direct |
2,610
-14.45%
|
$99,180
$38.25 P/Share
|
|
Aug 07
2023
|
Terry D Schlotterback Director |
SELL
Payment of exercise price or tax liability
|
Direct |
529
-2.85%
|
$20,631
$39.69 P/Share
|
|
Aug 07
2023
|
Terry D Schlotterback Director |
BUY
Exercise of conversion of derivative security
|
Direct |
670
+3.48%
|
$20,100
$30.97 P/Share
|
|
Jul 28
2023
|
David R Bailey President and CEO |
SELL
Bona fide gift
|
Direct |
1,100
-0.76%
|
-
|
|
Jul 17
2023
|
Harold Ruf Director |
BUY
Bona fide gift
|
Indirect |
1,965
+9.43%
|
-
|
|
Jul 17
2023
|
Harold Ruf Director |
SELL
Bona fide gift
|
Direct |
1,965
-41.53%
|
-
|
|
Jun 26
2023
|
Fred Hite COO and CFO |
SELL
Open market or private sale
|
Direct |
4,356
-4.29%
|
$187,308
$43.69 P/Share
|
|
Jun 14
2023
|
Jimmy Duane Mc Donald Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,965
+50.0%
|
-
|
|
Jun 14
2023
|
George Sinclair Mitchell Dyer Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,965
+50.0%
|
-
|
|
Jun 14
2023
|
Bryan W Hughes Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,965
+16.34%
|
-
|
|
Jun 14
2023
|
(Reynolds) Marie C Infante Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,965
+18.6%
|
-
|
|
Jun 14
2023
|
Harold Ruf Director |
BUY
Bona fide gift
|
Indirect |
1,497
+8.9%
|
-
|
|
Jun 14
2023
|
Harold Ruf Director |
SELL
Bona fide gift
|
Direct |
1,497
-29.6%
|
-
|
|
Jun 14
2023
|
Harold Ruf Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,965
+27.98%
|
-
|
|
Jun 14
2023
|
David R Pelizzon Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,965
+8.28%
|
-
|
|
Jun 14
2023
|
Terry D Schlotterback Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,965
+9.88%
|
-
|
|
Jun 14
2023
|
Samuel D Riccitelli Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,965
+17.51%
|
-
|
|
Apr 27
2023
|
Gregory A Odle President of Scoliosis |
SELL
Open market or private sale
|
Direct |
3,333
-3.85%
|
$166,650
$50.1 P/Share
|
|
Apr 25
2023
|
Gregory A Odle President of Scoliosis |
SELL
Open market or private sale
|
Direct |
828
-0.95%
|
$41,400
$50.02 P/Share
|
|
Apr 21
2023
|
Gregory A Odle President of Scoliosis |
SELL
Open market or private sale
|
Direct |
644
-0.73%
|
$32,200
$50.02 P/Share
|
|
Mar 15
2023
|
Daniel J Gerritzen General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
19,617
+26.24%
|
-
|
|
Mar 15
2023
|
David R Bailey President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
44,444
+23.47%
|
-
|
|
Mar 15
2023
|
Fred Hite COO and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+22.79%
|
-
|
|
Mar 15
2023
|
Mark C Throdahl Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,266
+8.04%
|
-
|
|
Mar 15
2023
|
Gregory A Odle President of Scoliosis |
BUY
Grant, award, or other acquisition
|
Direct |
19,617
+18.22%
|
-
|
|
Mar 15
2023
|
Joseph W Hauser Pres. Trauma & Def. Correction |
BUY
Grant, award, or other acquisition
|
Direct |
19,617
+26.02%
|
-
|